3-LDV | ENHANCED DELIVERY OF NANOMEDICINE TO KIDNEY GRAFT ENDOTHELIAL CELLS DURING EX VIVO PERFUSION | Claire ALBERT | Received |
3-OP | CRISPR-CAS9 HLA-DELETED GLOMERULAR ENDOTHELIAL CELLS AS A TOOL TO DETECT PATHOGENIC NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS | Baptiste Lamarthée | Received |
6-OP | TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODY-MEDIATED REJECTION | Gesa Tiller | Received |
7-OP | CD56DIM CD16BRIGHT NK CELLS DURING ANTIBODY-MEDIATED REJECTION DISPLAY INCREASED PROLIFERATION, ACTIVATION AND TYPE-1 INFLAMMATORY CYTOTOXIC PROFILES | Elodie Bailly | Received |
9-OP | WATERLOW SCORE ON ADMISSION AND POST-SURGERY RISK OF PROLONGED LENGTH OF STAY, EMERGENCY READMISSION AND MORTALITY RISK | Anna Brotherton | Received |
10-OP | FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Evelien Quint | Received |
11-OP | ASSESSING RISK FACTORS OF NON-ADHERENCE AND POST-TRANSPLANT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS | Kateryna Maksyutynska | Received |
12-OP | IMPACT OF THE COVID-19 PANDEMIC ON DAILY LIVES, EMOTIONS AND BEHAVIOURS OF KIDNEY TRANSPLANT RECIPIENTS | Regina Van Zanten | Received |
13-OP | SOCIAL DISTRESS AND HEALTH-RELATED QUALITY OF LIFE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Noor Al Kaabi | Received |
14-OP | RENAL TRANSPLANT OUTCOMES IN YOUNG ADULTS BEFORE AND AFTER THE INTRODUCTION OF A YOUNG ADULT SERVICE | Laura Baines | Received |
15-OP | SUPPORTING TEENAGE AND YOUNG ADULT TRANSPLANT RECIPIENTS DURING COVID-19 PANDEMIC USING A SOCIAL MEDIA PATIENT GROUP | Daley Cross | Received |
16-OP | SHORT- AND LONG-TERM PREGNANCY OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN THE NETHERLANDS | Jildau Meinderts | Received |
17-OP | FATIGUE AMONG HEART RECIPIENTS- A BARRIER TO SELF-EFFICACY? | Matilda Almgren | Received |
18-OP | SYMPTOM OCCURRENCE AND DISTRESS AFTER HEART TRANSPLANTATION - A NATIONWIDE CROSS-SECTIONAL COHORT STUDY. | Marita Dalvindt | Received |
19-OP | RECOVERY AND SELF-EFFICACY AFTER HEART TRANSPLANTATION- IMPORTANT ASPECTS OF SELF-MANAGEMENT | Matilda Almgren | Received |
20-OP | THE MEANING OF SURVIVING THREE YEARS AFTER A HEART TRANSPLANT - A TRANSITION FROM UNCERTAINTY TO ACCEPTANCE THROUGH ADAPTATION | Anna Forsberg | Received |
21-OP | FATIGUE, SELF-EFFICACY AND RECOVERY 1-5 YEARS AFTER LUNG TRANSPLANTATION | Annette Lennerling | Received |
22-OP | ADAPTATION AFTER LUNG TRANSPLANTATION UP TO THREE YEARS AFTER TRANSPLANTATION. | Martina Lundmark | Received |
23-OP | OUTCOME OF LIVER TRANSPLANTATION FOR NON-HCC MALIGNANCIES – A COLLABORATIVE TRANSPLANT STUDY REPORT | Philipp Houben | Received |
25-OP | DIFFERENT PATTERNS OF RECURRENCE AFTER LIVER RESECTION AND TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS | Jorgelina Coppa | Received |
26-OP | LONG TERM OUTCOMES AFTER LIVER TRANSPLANTATION VERSUS RESECTION FOR MILAN-IN NEUROENDOCRINE TUMOR LIVER METASTASES | Marianna Maspero | Received |
27-OP | UNRESECTABLE GASTROINTESTINAL STROMAL TUMOR (GIST) LIVER METASTASES AS A NEW INDICATION FOR LIVER TRANSPLANTATION. HAS ITS TIME ARRIVED? | Felipe Alconchel | Received |
31-OP | EVOLUTION OF PATIENTS WITH DEVASTATING BRAIN INJURY ADMITTED IN INTENSIVE CARE UNIT FOR INTENSIVE CARE TO FACILITATE ORGAN DONATION | Alicia Perez | Received |
32-OP | PERCEIVED AND VERIFIED CANCER HISTORY IN POTENTIAL SOLID ORGAN DONORS: AN AUSTRALIAN COHORT STUDY | James Hedley | Received |
34-OP | THE ROLE OF THE SURGICAL CARE PRACTITIONER IN ORGAN RETRIEVAL: A SINGLE-CENTRE EXPERIENCE | Francesco Abbadessa | Received |
35-OP | ASSESSMENT OF DONOR-RECIPIENT SIZE MISMATCH BASED ON BODY SURFACE AREA INDEX AND ITS IMPLICATIONS ON OUTCOMES OF DECEASED-DONOR LIVER TRANSPLANTS | Ioannis D. Kostakis | Received |
38-OP | FACING THE CHALLENGE: TRANSPLANT ACCESS FOR THE HIGHEST SENSITIZED PATIENTS (CPRA=100%). THE SPANISH EXPERIENCE | Maria O Valentin | Received |
39-OP | IMPACT OF INHIBITION OF PCSK-9 AMONG RENAL TRANSPLANT RECIPIENTS WITH HIGH CARDIOVASCULAR RISK | Osama Gheith | Received |
40-OP | IMPACT OF FULL CORRECTION OF POST-TRANSPLANT ANEMIA ON CARDIOVASCULAR SYSTEM IN RENAL TRANSPLANT RECIPIENTS RECEIVING ESA: PROSPECTIVE RCT | Ayman Maher Nagib | Received |
41-OP | IS ERYTHROCYTOSIS MORE FREQUENT AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION?: A SINGLE-CENTER EXPERIENCE | Marina Reis | Received |
42-OP | COMPARING SURVIVAL OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS WITH PRE-EXISTING DIABETES VERSUS THOSE WHO DEVELOP POST-TRANSPLANTATION DIABETES | Azm Hussain | Received |
43-OP | OUTCOMES OF SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES | Tarek Mahmoud | Received |
44-OP | HLA ALLELES CW12 AND DQ4 IN KIDNEY TRANSPLANT RECIPIENTS ARE INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANTATION DIABETES | Azm Hussain | Received |
45-OP | SEMAGLUTIDE IS A SAFE AND EFFECTIVE TREATMENT IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POST-TRANSPLANT DIABETES MELLITUS | Maarten Tushuizen | Received |
46-OP | DETERMINATS OF THE APPERANANCE OF POST TRANSPLANT DIABETES MELLITUS AFTER KINDEY TRASNAPLANTION | Maria Smyrli | Received |
47-OP | AMPUTATION AND ULCERATION IN TYPE-1 DIABETIC PATIENTS UNDERGOING SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION: A SYSTEMATIC REVIEW | Jineel Raythatha | Received |
48-OP | EVEROLIMUS, GLUCOSE METABOLISM, AND ANTI- VISCERAL OBESITY EFFECT IN KIDNEY TRANSPLANT CANDIDATES | Mikiko Yoshikawa | Received |
49-OP | OUTCOMES OF LIVER TRANSPLANTS FOR NASH FROM A LARGE SINGLE INSTITUTIONAL COHORT | Aamir Nawaz | Received |
50-OP | VARIATIONS IN TM6SF2 RS58542926, PCSK9 RS505151 AND PCSK7 RS2277287 WITH THE RISK OF HEPATIC STEATOSIS AFTER LIVER TRANSPLANTATION | Ahad Eshraghian | Received |
51-OP | IMPACT OF ELECTIVE LIGATION OF A PATENT ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS ON BLOOD PRESSURE AND SERUM LEVELS OF CARDIAC BIOMARKERS | Gregoire Masson | Received |
52-OP | POSITIVE IMPACT OF KIDNEY TRANSPLANTATION ON OLFACTORY ABILITY: RESULTS OF A CROSS-SECTIONAL CASE CONTROL STUDY. | Chiara Caletti | Received |
53-OP | IMPACT OF FCGR3A POLYMORPHISMS ON AMR OUTCOME AND IVIG RESPONSE IN KIDNEY TRANSPLANT RECIPIENTS | Alice Koenig | Received |
54-OP | THE FCGR3A-158 V/V-GENOTYPE IS ASSOCIATED WITH DECREASED SURVIVAL OF RENAL ALLOGRAFTS WITH CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION | Nicolle Litjens | Received |
55-OP | PREFORMED T-CELL ALLOIMMUNITY AND HLA EPLET MISMATCH TO GUIDE IMMUNOSUPPRESSION MINIMIZATION WITH TACROLIMUS MONOTHERAPY IN KIDNEY TRANSPLANTATION. | Maria Meneghini | Received |
56-OP | HLA EPITOPE MISMATCHES IN KIDNEY TRANSPLANT RECIPIENTS WITH HISTOLOGICAL ANTIBODY-MEDIATED REJECTION WITH AND WITHOUT HLA DONOR-SPECIFIC ANTIBODIES | Laura Llinàs-Mallol | Received |
57-OP | UNSUPERVISED MACHINE LEARNING IDENTIFIES FAST AND SLOW MODULATION OF DSA DYNAMICS FOLLOWING HLA- INCOMPATIBLE TRANSPLANTATION – 5 YEAR OUTCOMES. | Sunil Daga | Received |
58-OP | MYELOID-DERIVED SUPPRESSOR CELLS IN KIDNEY TRANSPLANT RECIPIENTS AND THE EFFECT OF MAINTENANCE IMMUNOTHERAPY | Maria Iglesias Escudero | Received |
59-OP | CLINICAL VALUE OF THE USE OF COMPLETE HIGH RESOLUTION HLA TYPING FOR THE DEFINITION OF DNDSA AFTER KIDNEY TRANSPLANTATION | Maria Meneghini | Received |
60-OP | DONOR-SPECIFIC ELISPOT ASSAY FOR PREDICTING ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Suwasin Udomkarnjananun | Received |
61-OP | HLA AND NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTOLOGICAL PICTURE OF ANTIBODY-MEDIATED REJECTION | Laura Llinàs-Mallol | Received |
62-OP | DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AND ABMR IN RENAL TRANSPLANT PATIENTS DEPENDS ON CYP3A5 GENOTYPE | Justa Friebus-Kardash | Received |
63-OP | EVOLUTION OF HUMORAL LESIONS ON CONTROL BIOPSY STRATIFIES THE RISK FOR RENAL GRAFT LOSS AFTER ANTIBODY-MEDIATED REJECTION TREATMENT | Antonin Bouchet | Received |
64-OP | CHALLENGING EARLY CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION AFTER SUCCESSFUL DESENSITIZATION FOR CDC-CROSSMATCH-POSITIVE KIDNEY TRANSPLANTION. | Annelies De Weerd | Received |
65-OP | TEMRA CD8 T CELLS FROM KIDNEY TRANSPLANT RECIPIENTS EXHIBIT ENHANCED PURINERGIC P2X4 RECEPTOR-DEPENDENT PROINFLAMMATORY AND MIGRATORY RESPONSES | Nicolas Degauque | Received |
66-OP | GRANZYME B POSITIVE B CELLS ENRICH REGULATORY T CELL COMPARTMENT AND INDUCE INHIBITION OF EFFECTOR CD4+ CD25- T CELL RESPONSE. | Nicolas Sailliet | Received |
67-OP | THE IMPACT OF DONOR AND RECIPIENT SIZE IN PAEDIATRIC RENAL TRANSPLANTATION | Ioannis D. Kostakis | Received |
68-OP | UK CONSENSUS ON SURGICAL TECHNIQUES IN PAEDIATRIC RENAL TRANSPLANT | John Fallon | Received |
69-OP | IMPACT OF VASCULAR ANOMALIES ON SURGICAL COMPLICATIONS AND OUTCOME IN PEDIATRIC KIDNEY TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER ANALYSIS. | Gionata Spagnoletti | Received |
70-OP | FINAL HEIGHT OF CHILDREN OVER 12 YEARS INITIATED ON A STEROID MINIMISATION IMMUNOSUPPRESSIVE REGIMEN FOLLOWING KIDNEY TRANSPLANTATION | Demetria Theodorou | Received |
71-OP | IMPACT OF DONOR HUMAN LEUKOCYTE ANTIGEN SPECIFIC ANTIBODIES DETECTED IN PEDIATRIC KIDNEY TRANSPLANT PATIENTS WITH STABLE OR DECLINED GRAFT FUNCTION | Asimina Fylaktou | Received |
73-OP | STANDARDISATION OF IMMUNOSUPPRESSIVE AND ANTI-INFECTIVE DRUG REGIMENS IN UK PAEDIATRIC RENAL TRANSPLANTATION: THE HARMONISATION PROGRAMME | Stephen D Marks | Received |
74-OP | KIDNEY TRANSPLANTED CHILDREN NOT RESPONDING TO ANTI-REJECTION TREATMENT: HOW TO IMPROVE THE OUTCOME | Irene Alberici | Received |
77-OP | LUNG TRANSPLANT FOR PULMONARY FIBROSIS; SMALLER DONOR LUNGS IMPACT SURVIVAL | Gillian Hardman | Received |
81-OP | DONOR LYMPHOCYTES IN PERIPHERAL BLOOD OF PATIENTS AFTER LUNG TRANSPLANTATION COMPRISE HIGH FREQUENCIES OF KIR-POSITIVE T AND NK CELL SUBSETS | Jenny Kuehne | Received |
82-OP | MIR-339 AND GALECTIN-3: DIAGNOSTIC VALUE IN PATIENTS WITH AIRWAY OBSTRUCTION AFTER LUNG TRANSPLANTATION | Olga Gichkun | Received |
86-OP | MONITORING OF ANTIVIRAL IMMUNE RESPONSE AS AN INDICATOR OF IMMUNOSUPPRESSION INTENSITY AND OUTCOME AFTER KIDNEY TRANSPLANTATION: THE VIRENO STUDY | Veronica Di Cristanziano | Received |
87-OP | LUMINAL ACTIVATION OF COMPLEMENT WITH APICAL DEPOSITION OF C3DG AND C5B-9 IN THE PROXIMAL TUBULES IN KIDNEY TRANSPLANT RECIPIENTS | Gustaf Isaksson | Received |
88-OP | THE UPTAKE OF THE PET RADIOTRACER 18-FLUORODEOXYGLUCOSE BY THE RENAL ALLOGRAFT CORRELATES WITH THE ACUTE BANFF SCORES OF CORTEX INFLAMMATION | Francois Jouret | Received |
91-OP | OBSERVATIONS ON 24-HOUR EX SITU NORMOTHERMIC LIVER PERFUSION | Amelia Hessheimer | Received |
95-OP | ASSOCIATION OF PROCUREMENT TIME WITH SHORT- AND LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION | Verner Eerola | Received |
96-OP | HEPATITIS B OCCULT INFECTION IN DECEASED LIVER DONORS: LONG TERM POST TRANSPLANT CLINICAL EVALUATION. | Davide Cussa | Received |
97-OP | PROPOSAL AND VALIDATION OF A LIVER GRAFT DISCARD SCORE FOR LIVER TRANSPLANTATION: A MULTICENTRE ITALIAN STUDY | Fabio Melandro | Received |
98-OP | EXTENDED CRITERIA DONORS IN LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Francesco Giovinazzo | Received |
99-OP | DONATION AFTER CIRCULATORY DEATH LIVERS CAN BE SAFELY USED FOR TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING PORTAL VEIN THROMBOSIS | Willemijn Van Der Plas | Received |
100-OP | RISK FACTORS ASSOCIATED WITH HISTOLOGICAL INJURY TO THE DEEP PERIBILIARY GLANDS AND PERIBILIARY VASCULAR PLEXUS PRIOR TO LIVER TRANSPLANTATION | Willemijn Van Der Plas | Received |
101-OP | INDICATIONS AND WAITING LIST PRIORITY FOR DECEASED DONOR LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS IN JAPAN. | Susumu Eguchi | Received |
102-OP | RECENT TRENDS AND INTENTION-TO-TREAT SURVIVAL OF LIVER TRANSPLANTATION FOR NONALCOHOLIC STEATOHEPATITIS:AN ITALIAN LIVER TRANSPLANT REGISTRY STUDY | Chiara Di Renzo | Received |
103-OP | OUTCOMES OF DONORS WITH BMI=30 FOR LIVING DONOR LIVER TRANSPLANTATION | Oya Andacoglu | Received |
104-OP | PERFORMANCE OF ARTIFICIAL INTELLIGENCE IN PREDICTING SURVIVAL FOLLOWING LIVER TRANSPLANTATION: STUDY USING DATA FROM THE KOREAN TRANSPLANT REGISTRY | Young-Dong Yu | Received |
105-OP | UPDATE ON WAITLIST MORTALITY OF YOUNG PATIENTS WITH BILIARY ATRESIA - RESULTS FROM THE EUROTRANSPLANT DATABASE | Heda Esmati | Received |
106-OP | LIVER TRANSPLANTATION (LT) IN HIGH-MELD (= 30) PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): SINGLE-CENTER EXPERIENCE WITH 90 CASES | Andrea Della Penna | Received |
107-OP | EVOLUTION OF INDICATION IN LIVER TRANSPLANTATION IN ITALY: THE CNT REGISTRY STUDY; ECALITA STUDY. ON BEHALF OF ECALITA STUDY GROUP | Tommaso Maria Manzia | Received |
108-OP | IMPACT EXTENDED LIVING DONOR CRITERIA FOCUSING ON DONOR SAFETY IN LIVING DONOR LIVER TRANSPLANTATION | Joodong Kim | Received |
109-OP | HLA-DQ DISPARITIES AND KIDNEY TRANSPLANT OUTCOME | Aleksandar Senev | Received |
110-OP | KIDNEY RECIPIENTS CHARACTERISTICS QUESTIONED THE DISCRIMINATIVE CAPACITIES OF KIDNEY DONOR RISK INDEX: AN EXTERNAL VALIDATION FROM A FRENCH COHORT | Anne-Hélène Querard | Received |
111-OP | DONOR FACTORS -FOR KIDNEYS ACCEPTED FOR TRANSPLANTATION- MARGINALLY IMPACT TRANSPLANT OUTCOMES. CONCLUSIONS FROM NATIONWIDE PAIRED OUTCOME ANALYSES | Jan Lindeman | Received |
112-OP | IMPACT OF ASIAN AND BLACK DONOR AND RECIPIENT ETHNICITY ON THE OUTCOMES AFTER DECEASED DONOR KIDNEY TRANSPLANTATION IN THE UNITED KINGDOM | Abdul Rahman Hakeem | Received |
113-OP | PREDICTING NUCLEAR RENOGRAPHY BASED SPLIT RENAL FUNCTION IN LIVING DONOR TRANSPLANTATION WITH CT BASED MEASURED SPLIT RENAL VOLUMES | Bahattin Ozkul | Received |
114-OP | EPITOPE DISTRIBUTION AND FEASIBILITY OF PIRCHE-II T-CELL MATCHING FOR RENAL TRANSPLANTATION IN CANADA | Karen R Sherwood | Received |
115-OP | ITALIAN NATIONAL KIDNEY ALLOCATION ALGORHITM (INKAA): APPLICATION AND FIRST RESULTS | Andrea Ricci | Received |
116-OP | THE IMPACT OF COLD ISCHAEMIA TIME ON OUTCOMES OF LIVING DONOR KIDNEY TRANSPLANTATION IN THE UK LIVING KIDNEY SHARING SCHEME | Stijn Van De Laar | Received |
117-OP | CLOSING THE GAP: EXAMINING WAIT LIST OUTCOMES FOR THE MOST HIGHLY SENSITIZED CANDIDATES IN THE USA ACROSS REGIONS | Miriam Manook | Received |
118-OP | THE REMUZZI SCORE IS A SAFE DECISION-MAKING TOOL AND UTILIZES MORE KIDNEYS FOR TRANSPLANT COMPARED TO DONOR EGFR | Annemarie Weissenbacher | Received |
119-OP | LONG-TERM EVOLUTION OF KIDNEY GRAFT DONATION PROCEDURES IN UNCONTROLLED DONORS AFTER CARDIAC DEATH IN THE COMMUNITY OF MADRID | Alonso Mateos-Rodriguez | Received |
120-OP | MODIFIED FRAILITY INDEX (MFI-11): A SIMPLE TOOL TO ACCESS FRAILTY IN OLDER KIDNEY TRANSPLANT WAITING LIST POPULATION | Mariana Sousa | Received |
121-OP | COMPARING OUTCOMES IN RIGHT VERSUS LEFT KIDNEY TRANSPLANTATION; A SYSTEMATIC REVIEW AND META-ANALYSIS | Caitlin Carolan | Received |
122-OP | ARE UNSPECIFIED KIDNEY DONORS TREATED DIFFERENTLY TO SPECIFIED KIDNEY DONORS? VIEWS OF UK TRANSPLANT PROFESSIONALS | Mira Zuchowski | Received |
123-OP | UK DECEASED DONATION AND TRANSPLANT ACTIVITY IN PAEDIATRICS FOR 2019 – 2020 | Chloe Brown | Received |
124-OP | THE END STAGE RENAL DISEASE (ESRD) IN ANORECTAL MALFORMATION (ARM) PATIENTS: RISK FACTORS AND OUTCOME. | Miriam Duci | Received |
125-OP | PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Reshma Rana Magar | Received |
129-OP | THE OUTCOME OF PLASMA CELL-RICH ACUTE REJECTION IN KIDNEY TRANSPLANTATION, IS IT REALLY POOR? | Tarek Mahmoud | Received |
131-OP | HYPERACUTE HUMORAL NON-HLA ALLOGRAFT REJECTION AND PROTEIN S DEFICIENCY DISEASE, CASE REPORT AND REVIEW. | Luis Garcia Covarrubias | Received |
132-OP | ALLOIMMUNE CELLULAR AND HUMORAL MONITORING IN A KIDNEY TRANSPLANT RECIPIENT THAT PRESENTS AN ACUTE LEUKEMIA TREATED WITH BLINATUMOMAB | Paula Anton Pampols | Received |
138-OP | ORGAN DONOR WITH RT-PCR POSITIVE FOR SARS-COV-2, IS IT ALWAYS NO? | José Moya Sánchez | Received |
139-OP | ORGAN DONATION IN KSA: COVID-19 PANDEMIC | Besher Al-Attar | Received |
140-OP | BILATERAL PNEUMONIA IN A KIDNEY TRANSPLANT RECIPIENT THE COVID-19 ERA- SOMETIMES IT´S A ZEBRA | Bojana Šimunov | Received |
141-OP | IMPACT OF THE CHANGE IN ORGAN DONATION LAW IN ENGLAND ON DONATION RATES IN THE MULTICULTURAL AND ETHNICALLY DIVERSE CITY OF LONDON | Lucy Dames | Received |
142-OP | OPT OUT LEGISLATION IN THE UK – PRELIMINARY DATA | Sue Madden | Received |
143-OP | DISPARITIES IN THE USE OF DONATION AFTER CARDIAC DEATH LIVER ALLOGRAFTS FROM DONORS OVER 60 YEARS OF AGE IN THE UNITED STATES VS. THE UNITED KINGDOM. | Emmanouil Giorgakis | Received |
145-OP | COMPUTERISED INTEGRATION OF ALTERNATIVE LIVING DONOR KIDNEY TRANSPLANTATION PROGRAMS: FIRST PROMISING RESULTS FOR DIFFICULT-TO-MATCH PATIENTS | Marry De Klerk | Received |
146-OP | ALTRUISTIC KIDNEY DONATIONS: OPTIMIZING UTILITY AND BENEFICENCE | Muhammad Yahya Jan | Received |
149-OP | BETA-CELL DEATH, RATHER THAN INSULIN RESISTANCE, DRIVES HYPERGLYCAEMIA IN ORGAN DONORS. | Iestyn Shapey | Received |
151-OP | DIFFERENTIALLY METHYLATED CELL FREE DNA MONITORING IN PANCREAS TRANSPLANT RECIPIENTS WITH FUNCTIONING GRAFT | Maria José Ramírez-Bajo | Received |
153-OP | UTILITY OF DONOR-DERIVED CELL-FREE DNA IN PANCREAS-KIDNEY TRANSPLANTATION | Pedro Ventura-Aguiar | Received |
154-OP | EFFICACY AND SAFETY OF PANCREAS TRANSPLANT ALONE (PTA) IN SUBJECTS WITH TYPE 1 DIABETES (T1D): 15 YEAR ACTUAL FOLLOW-UP | Walter Baronti | Received |
161-OP | THE EXPRESSION LEVELS OF CIRCULATING MIR-101 AND MIR-27 ASSOCIATE WITH HEART TRANSPLANT ACUTE REJECTION | Olga Gichkun | Received |
162-OP | REAL WORLD DATA OF EVEROLIMUS WITH OR WITHOUT CALCINEURIN-INHIBITORS ON LONGTERM OUTCOME AFTER HEART TRANSPLANTATION | Markus J. Barten | Received |
170-OP | MEDICATION ADHERENCE AND FEAR OF REJECTION AFTER CONVERSION FROM DUAL TO MONOTHERAPY: A RANDOMIZED CONTROLLED TRIAL | Regina Van Zanten | Received |
172-OP | I-DTI: A SECOND OPINION PLATFORM BETWEEN HEALTHCARE PROFESSIONALS RELATED TO ORGAN DONATION AND TRANSPLANTATION | Estephan Arredondo | Received |
176-OP | CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION | Angela Carvalho-Gomes | Received |
180-OP | RECIPIENT SEX AND ESTRADIOL LEVELS AFFECT TRANSPLANT OUTCOMES IN AN AGE-SPECIFIC FASHION | Jasper Iske | Received |
181-OP | CXCR3+ CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES COULD HELP IN COVID-19 RESOLUTION IN KIDNEY TRANSPLANT RECIPIENTS | Patricia Suàrez Fernández | Received |
182-OP | INCREASING DIAGNOSTIC ACCURACY IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE BY T CELL ANALYSIS IN PERIPHERAL BLOOD AND BIOPSY | Ulrik Stervbo | Received |
183-OP | DETECTION OF PRE-EXISTING SARS-COV-2-REACTIVE T CELLS IN UNEXPOSED RENAL TRANSPLANT PATIENTS | Arturo Blázquez Navarro | Received |
184-OP | COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS | Francisco Gonçalves | Received |
185-OP | OUTCOMES OF KIDNEY TRANSPLANTATION AT THE EPICENTRE OF THE COVID-19 PANDEMIC: THE EXPERIENCE OF THE OSPEDALE MAGGIORE POLICLINICO | Evaldo Favi | Received |
186-OP | IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION | Anna Sessa | Received |
187-OP | LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS RECOVERED FROM COVID-19 INFECTION | Ahad Eshraghian | Received |
188-OP | SARS-COV-2 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: ONE YEAR LATER. WHAT HAVE WE LEARNT? | Joana Tavares | Received |
189-OP | LIVER TRANSPLANT RECIPIENTS WITH SARS-COV-2 INFECTION: RESULTS FROM AN ITALIAN MULTICENTER COHORT | Chiara Mazzarelli | Received |
190-OP | COVID-19 MANAGEMENT IN PATIENTS AFTER HEART TRANSPLANTATION | Maria Simonenko | Received |
191-OP | COVID-19 IN DECEASED RENAL TRANSPLANT RECIPIENTS | Mariana Sousa | Received |
192-OP | EPIDEMIOLOGY AND CLINICAL RELEVANCE OF ACUTE KIDNEY INJURY IN COVID-19 KIDNEY TRANSPLANT RECIPIENTS | Gabriele Guglielmetti | Received |
193-OP | INFLUENZA VACCINATION IN SOLID ORGAN TRANSPLANT RECIPIENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY | Susanne Dam Nielsen | Received |
194-OP | KIDNEY TRANSPLANT PATIENTS ARE ABLE TO GENERATE AND MOUNT VARICELLA ZOSTER-REACTIVE T CELL AND HUMORAL IMMUNITY FOLLOWING VARICELLA ZOSTER VACCINATION | Toralf Roch | Received |
195-OP | CORRELATION BETWEEN COLD ISCHEMIA TIME AND THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION | Marco Maria Pascale | Received |
196-OP | DANGER SIGNALS IN ORGAN PRESERVATION SOLUTION AFTER COLD ISCHEMIA IN LIVER TRANSPLANTATION: ACTIVATION OF MACROPHAGES AND ENDOTHELIAL CELLS | Alberto Baroja-Mazo | Received |
197-OP | ROLE OF ACETYLCHOLINE IN LIVER GRAFTS FROM BRAIN DEAD DONORS WITH HEALTHY AND MARGINAL LIVERS WITH SIMPLE STEATOSIS OR NON-ALCOHOLIC STEATOHEPATITIS | Marc Micó Carnero | Received |
198-OP | PERSISTENT BILIARY HYPOXIA AND LACK OF REGENERATION ARE KEY MECHANISMS IN THE PATHOGENESIS OF NON-ANASTOMOTIC STRICTURES AFTER LIVER TRANSPLANTATION | Iris De Jong | Received |
199-OP | ANG-3777 TREATMENT ATTENUATES ISCHEMIA-REPERFUSION-INDUCED RENAL INJURY IN RAT AND DOG MODELS | Prakash Narayan | Received |
200-OP | INFLUENCE OF THE ANESTHETIC METHOD ON THE OUTCOME OF A RODENT MODEL OF INTESTINAL ISCHEMIA-REPERFUSION INJURY | Mathias Clarysse | Received |
201-OP | CLINICALLY APPLICABLE INTRALUMINAL PRESERVATION OF HUMAN SMALL BOWEL DOES NOT REDUCE HISTOLOGICAL DAMAGE COMPARED TO STANDARD VASCULAR FLUSH | Anne Marye De Jong | Received |
202-OP | CALCIUM CARBONATE NANOPARTICLES IN AN EX VIVO RAT INTESTINAL PERFUSION MODEL: PREVENTION OF ISCHEMIC INJURY IN COLON AND SMALL INTESTINE | Michele Finotti | Received |
203-OP | L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODE | Michele Finotti | Received |
204-OP | ATTENUATION OF INTESTINAL ISCHEMIA-REPERFUSION INJURY IN A RODENT MODEL BY INTRAVENOUS ADMINISTRATION OF POLYETHYLENE GLYCOL | Mathias Clarysse | Received |
205-OP | IN VIVO PHOSPHORYLATION OF C-MET BY ANG-3777, A HEPATOCYTE GROWTH FACTOR MIMETIC | Latha Paka | Received |
206-OP | OXYGENATED VERSUS NON-OXYGENATED FLUSH OUT AND STORAGE OF DCD PORCINE LIVERS | Isabel Brüggenwirth | Received |
207-OP | THE IRRADIATION-INDUCED RENAL ISCHEMIC PRECONDITIONING IS BLUNTED BY THE ORAL ADMINISTRATION OF THE ANTI-ANGIOGENIC AGENT, SUNITINIB | Badr Khbouz | Received |
208-OP | ILOPROST INFUSION ACCELERATES THE RECOVERY OF RENAL FUNCTION IN PATIENTS EXPERIENCING IRI-RELATED DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANT | Antonella Troiano | Received |
209-OP | IDENTIFICATION OF PREDICTIVE MARKERS FOR THE GENERATION OF WELL-DIFFERENTIATED IPSC-DERIVED KIDNEY ORGANOIDS | Zhaoyu Du | Received |
211-OP | PORTAL VENOUS REPOPULATION OF DECELLULARISED RAT LIVER SCAFFOLDS WITH SYNGENEIC BONE MARROW STEM CELLS | Mekhola Hoff | Received |
215-OP | IMPACT OF DELAYED GRAFT FUNCTION ON BASELINE DONOR DERIVED CELL-FREE DNA (DD-CFDNA) IN KIDNEY TRANSPLANT RECIPIENTS | Bhavna Chopra | Received |
220-OP | DIFFERENTIALLY EXPRESSED TISSUE MICRORNAS DISTINGUISH SPECIFIC DISEASE PHENOTYPES FOLLOWING KIDNEY TRANSPLANTATION | Špela Borštnar | Received |
228-OP | MAINTENANCE OF A DECEASED-DONOR KIDNEY TRANSPLANTATION PROGRAM DURING PANDEMIC SARS-COV-2 | Richard Dumbill | Received |
230-OP | IS IT SAFE TO RECEIVE KIDNEYS FROM DECEASED KIDNEY DONORS WHO TESTED POSITIVE FOR COVID-19 INFECTION? | Hatem Ali | Received |
231-OP | A NATIONAL RESPONSE TO COVID PRIORITISING LIVER TRANSPLANT RECIPIENTS WITH THE HIGHEST NEED PROVIDED EXCELLENT OUTCOMES IN THE UK | Steven Masson | Received |
232-OP | COVID-19 IN LIVER TRANSPLANT CANDIDATES: WAIT-LIST OUTCOMES AND POST-TRANSPLANT COURSE | Giovanni Perricone | Received |
233-OP | PANCREAS TRANSPLANTATION IN THE TIME OF COVID. A SINGLE CENTRES EXPERIENCE | Ann Etohan Ogbemudia | Received |
234-OP | A CASE SERIES OF PAEDIATRIC KIDNEY TRANSPLANTS DURING THE ONGOING COVID-19 PANDEMIC | Sergio Assia-Zamora | Received |
235-OP | ANASTOMOSIS TIME IS AN INDEPENDENT RISK FACTOR FOR PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY | Christelle M. Vandervelde | Received |
236-OP | FEASIBILITY OF SURVEILLANCE AFTER LUNG TRANSPLANTATION USING MULTIVOLUME MRI INSTEAD OF IONIZING RADIATION TECHNIQUES IN CYSTIC FIBROSIS PATIENTS | Alessandro Palleschi | Received |
237-OP | CHRONIC KIDNEY DISEASE: A FREQUENT COMPLICATION IN PATIENTS WITH LUNG TRANSPLANT | Marisa Serrano Salazar | Received |
238-OP | COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG | Víctor Donoso Trenado | Received |
239-OP | CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN | Raquel López-Vilella | Received |
240-OP | IS HEART TRANSPLANTATION A VALUABLE OPTION IN PATIENTS WITH SYSTEMIC RARE DISEASES? | Concetta Di Nora | Received |
241-OP | SINGLE CENTER ASSESSMENT OF CARDIAC TRANSPLANTATION RESULTS COMPARING URGENT VERSUS ELECTIVE REGIMEN | Mariafrancesca Fiorentino | Received |
242-OP | WAITLIST OUTCOMES AFTER THE IMPLEMENTATION OF A NEW ALLOCATION SYSTEM FOR URGENT HEART TRANSPLANTATION IN ITALY | Alessandra Oliveti | Received |
243-OP | LIFE OF AN HEART FAILURE AND HEART TRANSPLANT CENTER IN THE COVID ERA : NEVER GIVE IN TO FEAR, USE TELEMEDICINE. | Marco Masetti | Received |
244-OP | MYOCARDIAL SCAR BURDEN CORRELATES WITH CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION AND NT-PROBNP SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | Received |
245-OP | DECREASED CIRCULATING CD34+ CELL COUNT IS ASSOCIATED WITH CORONARY ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | Received |
246-OP | MONITORING LYMPHOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD IN HEART TRANSPLANT RECIPIENTS. A NEW TOOL TO DETECT CAV? | Clara Simón Ramón | Received |
247-OP | RISK FACTORS AND OUTCOMES OF ACUTE KIDNEY INJURY AFTER HEART TRANSPLANT | Nicolina Conti | Received |
248-OP | THE RISK OF SKIN CANCER DOES NOT CORRELATE WITH VITAMIN D SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS | Gregor Poglajen | Received |
249-OP | MAGNETIC RESONANCE IMAGING TO ASSESS RENAL FLOW DISTRIBUTION DURING EX VIVO NORMOTHERMIC MACHINE PERFUSION | Veerle A. Lantinga | Received |
251-OP | DONATION AFTER CIRCULATORY DEATH (DCD) STRATEGY IN ITALY: THE BARRIER OF A PROLONGED NO-TOUCH PERIOD CAN BE OVERCOME | Lucia Masiero | Received |
252-OP | NORMOTHERMIC LIQUID VENTILATION ATTENUATES INFLAMMATION FROM ISCHEMIA-REPERFUSION INJURY IN AN EX VIVO RAT MODEL | Helena M. Linge | Received |
253-OP | NORMOTHERMIC MACHINE PERFUSION FACILITATES DELIVERY OF RNA INTERFERENCE THERAPEUTICS IN DONOR KIDNEYS | Emily Thompson | Received |
254-OP | TREATING CIRCULATORY DEATH DONOR KIDNEYS WITH ANTI-FIBROTIC DRUGS USING EX VIVO PRECISION CUT KIDNEY SLICES | Leonie Van Leeuwen | Received |
255-OP | COMPLEMENT IS ACTIVATED DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE AND DISCARDED HUMAN KIDNEYS | Leonie Venema | Received |
256-OP | NORMOTHERMIC REGIONAL PERFUSION VERSUS RAPID RECOVERY IN CONTROLLED DONATION AFTER CIRCULATORY DEATH KIDNEY TRANSPLANTATION | Maria Padilla | Received |
257-OP | IMMUNE CELL PROFILING AND ASSESSMENT OF INFLAMMATORY CYTOKINE LEVELS IN THE PERFUSATE DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN LIVER ALLOGRAFTS | Margot Fodor | Received |
258-OP | EXPLORING THE RELEASE OF EXTRACELLULAR VESICLES IN PERFUSATE AND BILE AS AN ADDITIONAL TOOL TO UNRAVEL MECHANISMS OF FUNCTION OF LIVER NMP. | Nicholas Gilbo | Received |
259-OP | METABOLIC AND IMMUNOLOGICAL ALTERATIONS IN NORMOTHERMIC MACHINE PERFUSION OF THE LIVER AS COMPARED TO STATIC COLD STORAGE | Maria Letizia Lo Faro | Received |
261-OP | MICROVASCULAR OBSTRUCTIONS IN PORTAL BILE DUCT CAPILLARIES AND HEPATIC SINUSOIDS DURING NORMOTHERMIC MACHINE PERFUSION OF MARGINAL HUMAN LIVERS | Samuel Tingle | Received |
262-OP | RE-WRITING THE DEFINITION OF HIGH-RISK AND FUTILE DCD LIVER TRANSPLANTATION WITH NRP | Ahmed E Sherif | Received |
263-OP | BENCH SURGERY AND KIDNEY AUTO-TRANSPLANTATION IN RESCUE OF GERM-CELL RESIDUAL MASS. 3D MODELS UTILITY IN SURGICAL PLANNING | Victoria Gomez | Received |
265-OP | AN ALTERNATIVE WAY OF LAPAROSCOPIC PERITONEAL FENESTRATION BY USING A SECOND LAPAROSCOPE AND TRANSILLUMINATION TO MANAGE POST-TRANSPLANT LYMPHOCELES | Vasileios Tatsis | Received |
271-OP | INEQUITABLE ACCESS TO TRANSPLANTS: PERSONS WITH IMPAIRED DECISION-MAKING CAPACITY | Rebecca Thom | Received |
272-OP | FRIEND OR FOE: LAW, REGULATION AND THE PSYCHOSOCIAL ASSESSMENT OF LIVING KIDNEY DONORS | Bonnie Venter | Received |
273-OP | FAMILY´S LEGAL ROLE IN DECEASED ORGAN PROCUREMENT. AN EUROPEAN AND COMPARATIVE LAW STUDY | Marina Morla | Received |
274-OP | WITHDRAWING LIFE SUSTAINING TREATMENT AND ORGAN DONATION OF BRAIN DEATH PATIENTS | Seungrye Jeong | Received |
276-OP | H2S ENRICHED FLUSH-OUT IN DBD AND NON-DBD PORCINE KIDNEYS | Hanno Maassen | Received |
277-OP | PATTERNS AND INHIBITION OF CELL DEATH DURING STATIC COLD STORAGE OF HUMAN KIDNEYS | Jenna DiRito | Received |
278-OP | COMBINED DRUGS APPROACH TO PREVENT ISCHEMIA-REPERFUSION INJURY DURING TRANSPLANTATION OF LIVERS (CAPITL): RESULTS OF A RANDOMIZED CONTROLLED TRIAL | Nicolas Meurisse | Received |
280-OP | MODIFIED IMMUNE CELL (MIC) INFUSION IN KIDNEY TRANSPLANTATION | Christian Morath | Received |
281-OP | CHARACTERISATION OF DISTINCT GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS | Matthew Brook | Received |
282-OP | LONG TERM FOLLOW-UP OF LIVER TRANSPLANT RECIPIENTS AFTER ALLOGENEIC MESENCHYMAL STROMAL CELL INFUSION | Morgan Vandermeulen | Received |
283-OP | INCIDENCE AND PREDICTORS OF FAILED KIDNEY ALLOGRAFT INTOLERANCE SYNDROME | Carolina Ormonde | Received |
284-OP | LONG-TERM APHERESIS IN THE MANAGEMENT OF PATIENTS WITH RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION: A CASE SERIES | Audrey Uffing | Received |
285-OP | TRANSPLANTECTOMY VERSUS NON-TRANSPLANTECTOMY AFTER FAILED KIDNEY TRANSPLANT. A SYSTEMATIC REVIEW AND META-ANALYSIS. | Paschalis Gavriilidis | Received |
286-OP | ASSOCIATION BETWEEN DECEASED DONOR ACUTE KIDNEY INJURY ASSESSED BY BASELINE SERUM CREATININE BACK-ESTIMATION AND GRAFT SURVIVAL | Rémi Lenain | Received |
287-OP | CLINICAL AND IMMUNOLOGICAL FOLLOW-UP OF VERY LONG-TERM KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CALCINEURIN INHIBITORS | Amaury Dujardin | Received |
288-OP | DEEP-LEARNING BASED PREDICTION OF CLINICAL ENDPOINTS IN RENAL PRE-IMPLANTATION BIOPSIES USING SLIDE-LEVEL LABELS | Ka Ho Tam | Received |
289-OP | MOLECULAR AND CELLULAR MECHANISMS OF LIPOCALIN-2 MEDIATED RENOPROTECTION IN KIDNEY TRANSPLANTATION | Anna Pfefferkorn | Received |
290-OP | REVISITING THE CHANGES IN THE BANFF CLASSIFICATION FOR ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION | Jasper Callemeyn | Received |
291-OP | INTERSTITIAL FIBROSIS IN PREIMPLANTATION KIDNEY BIOPSIES OF EXTENDED CRITERIA DONORS PREDICTS LONG-TERM GRAFT SURVIVAL. | Elisabetta Bussalino | Received |
292-OP | THREE-MONTH GRAFT FUNCTION OF KIDNEYS RETRIEVED 4.5 HOURS AFTER CIRCULATORY DEATH | Deepti Antony | Received |
293-OP | ENDOTHELIAL TO MYOFIBROBLAST TRANSITION (ENMT) AND CAPILLARY VEGF LOSS ENHANCES THE DEVELOPMENT OF INTERSTITIAL FIBROSIS AND GLOMERULOSCLEROSIS | Binnaz Handan Ozdemir | Received |
294-OP | AGGRAVATION OF FIBRIN DEPOSITION AND MICROTHROMBUS FORMATION WITHIN THE GRAFT DURING KIDNEY TRANSPLANTATION | Tamar Van Den Berg | Received |
295-OP | HYPERLEPTINAEMIA AND LOW VALUES OF INTERLEUKIN 10 AS RISK FACTORS FOR GRAFT REJECTION IN PROTOCOL BIOPSY AFTER KIDNEY TRANSPLANTATION | Ivana Dedinská | Received |
296-OP | POST-TRANSPLANTATION EARLY BLOOD TRANSFUSION AND KIDNEY ALLOGRAFT OUTCOMES: A SINGLE-CENTER OBSERVATIONAL STUDY | Mehdi Maanaoui | Received |
299-OP | CORE SIGNATURE OF REJECTION-SPECIFIC CYTOKINES AND CHEMOKINES IN HEART BIOPSIES AFTER TRANSPLANTATION | Lena Radomsky | Received |
301-OP | CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE SCREENING OF CARDIAC ALLOGRAFT VASCULOPATHY, TWO YEARS OF EXPERIENCE | Stefan Roest | Received |
309-OP | MALIGNANCIES BEFORE AND AFTER HEART TRANSPLANTATION – A SINGLE-CENTRE LONG-TERM OUTCOME STUDY | Caroline Stenman | Received |
310-OP | CANCER TRANSMISSIONS AND NON-TRANSMISSIONS FROM SOLID ORGAN TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY | James Hedley | Received |
311-OP | SURVIVAL WITH TABELECLEUCEL IN PATIENTS WITH EPSTEIN-BARR VIRUS-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER SOLID ORGAN TRANSPLANT | S Prockop | Received |
312-OP | DONOR-TRANSMITTED CANCERS: THE SPANISH EXPERIENCE | Beatriz Dominguez-Gil | Received |
313-OP | SERIOUS ADVERSE EVENTS (SAE) AND SERIOUS ADVERSE REACTIONS (SAR) REPORTING IN GERMANY FROM 2016-2020: ANALYSIS OF DONOR-TRANSMITTED MALIGNANCY. | Klaus Böhler | Received |
314-OP | HETEROGENEOUS INFLUENCE OF DIFFERENT FORMS OF POST-TRANSPLANT DE NOVO CANCER ON SURVIVAL OF KIDNEY GRAFTS – A COLLABORATIVE TRANSPLANT STUDY REPORT | Christian Unterrainer | Received |
315-OP | POST-TRANSPLANT MALIGNANCIES AFTER PANCREAS TRANSPLANTATION: INCIDENCE AND IMPLICATIONS ON LONG-TERM OUTCOME FROM A SINGLE-CENTER PERSPECTIVE | Felix Julius Krendl | Received |
316-OP | T AND B CELL ABUNDANCE ARE STRONGLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES | Simon Schran | Received |
317-OP | IMPACT OF CANCER ON THE RISK OF DEATH AMONG ITALIAN KIDNEY TRANSPLANT RECIPIENTS WITH A FUNCTIONING GRAFT: ITALIAN TRANSPLANT & CANCER COHORT STUDY | Pierluca Piselli | Received |
318-OP | MANAGEMENT OF THE KIDNEY TRANSPLANT PATIENT WITH CANCER": REPORT FROM A CONSENSUS CONFERENCE. | Gionata Spagnoletti | Received |
319-OP | RETROSPECTIVE STUDY OF NEOPLASM TRANSMISSION FROM ORGAN DONOR TO RECIPIENT | Helena Martí Grífol | Received |
320-OP | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY | Stathis Tsiakas | Received |
321-OP | DISTINCT IMPACT OF POSTTRANSPLANT MALIGNANCIES AND MORTALITY IN DIFFERENT IMMUNOSUPPRESSIVE THERAPY PROTOCOLS BASED- PERIODS IN A LONG-TERM FOLLOW-UP | Ignacio Revuelta | Received |
322-OP | PREVALENCE AND CLINICAL SIGNIFICANCE OF PANCREATIC CYSTIC LESIONS IN IMMUNOSUPPRESSED PATIENTS WITH SOLID ORGAN TRANSPLANTATION | Young-Dong Yu | Received |
325-OP | PHASE 3 OPEN-LABEL STUDY OF MARIBAVIR FOR REFRACTORY/RESISTANT CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS: SUBGROUP ANALYSES BY ORGAN TYPE | Nassim Kamar | Received |
326-OP | SURVEILLANCE AND TREATMENT OF HUMAN HERPESVIRUS 8 IN TRANSPLANT RECIPIENTS: A STRICT PROTOCOL TO BRING MORTALITY TOWARD ZERO | alessandra mularoni | Received |
327-OP | MTOR INHIBITORS PREVENT CMV INFECTION THROUGH THE RESTORATION OF FUNCTIONAL ?? AND G? T CELLS IN KIDNEY TRANSPLANTATION | hannah kaminski | Received |
328-OP | PRECISION MEDICINE IN TRANSPLANTATION: MAGNITUDE, DURATION, AND IMPACT OF CMV VIREMIA ON GRAFT AND MORTALITY OUTCOMES | Paul A Keown | Received |
330-OP | BARIATRIC SURGERY COMPROMISES MACROPHAGE DRIVEN ALLOIMMUNITY IN OBESE TRANSPLANT RECIPIENTS | Jasper Iske | Received |
331-OP | MAXIMIZE THE USE OF ARTIFICIAL INTELLIGENCE IN ORGAN DONATION AND TRANSPLANTATION MANAGEMENT TO IMPROVE EFFICACY AND SAFETY | Wenshi Jiang | Received |
332-OP | OUTPATIENT URETERIC STENT REMOVAL FROM KIDNEY TRANSPLANT RECIPIENTS USING ISIRIS IS FEASIBLE, SAFE AND COST-EFFECTIVE | Fanourios Georgiades | Received |
333-OP | MULTILINEAR EGFR PROGRESSION PATTERN IS ASSOCIATED WITH GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS | Ruth Rahamimov | Received |
334-OP | PERSPECTIVES OF AUTOLOGOUS BLOOD TRANSFUSION AS A TOOL FOR PREVENTING IMMUNIZATION DURING NATIVE KIDNEY NEPHRECTOMY IN WAITING LIST CANDIDATES | Alicja Debska-Slizien | Received |
335-OP | QUALITY OF LIFE AFTER LIVER TRANSPLANTATION, A CROSS-SECTIONAL SINGLE CENTRE STUDY. | Mathias Vidgren | Received |
336-OP | QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY | Midas Mulder | Received |
337-OP | COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS | Midas Mulder | Received |
338-OP | CLIF-C ACLF SCORE DOES NOT PREDICT SURVIVAL AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE | Joris Blondeel | Received |
339-OP | LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE: A SINGLE CENTRE EXPERIENCE | Joris Blondeel | Received |
340-OP | VARIOUS SELECTION CRITERIA FOR PRETRANSPLANT MYOSTEATOSIS AND THEIR VALUE IN THE ASSESSMENT OF SHORT- AND LONG-TERM OUTCOMES FOLLOWING OLT | Zoltan Czigany | Received |
341-OP | ULTRA-LONG-TERM OUTCOME AND ITS DETERMINANTS AFTER LIVER TRANSPLANTATION IN ADULTS | Laura Boer | Received |
342-OP | THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY? | Michel Rayar | Received |
343-OP | A PHOTOGRAPH OF PATIENTS APPROACHING LIVER TRANSPLANTATION: ASSESSMENT OF THE PSYCHOLOGICAL OUTCOME PREDICTORS | Marco Valente | Received |
344-OP | AN ECONOMIC EVALUATION OF THE COST OF COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION IN THE UK NATIONAL HEALTH SYSTEM | Dimitri A. Raptis | Received |
346-OP | VIEWS AND EXPERIENCES OF PATIENTS AWAITING A TRANSPLANT AND OF TRANSPLANTED PATIENTS: A NATIONAL SURVEY TO UNDERSTAND THEIR NEEDS | Lia Bellis | Received |
348-OP | PSYCHOLOGICAL EVALUATION OF DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING COVID-19 | Sanem Cimen | Received |
352-OP | BILIARY RECONSTRUCTION USING HIGH BILIARY RADICAL IS SAFE OPTION FOR MULTIPLE GRAFT BILE DUCT IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION | JOODONG KIM | Received |
353-OP | RE-THINKING OF T-TUBE USE AT WHOLE LIVER TRANSPLANTATION: AN ANALYSIS ON THE RISK OF DELAYED GRAFT FUNCTION | Riccardo Pravisani | Received |
354-OP | POST-LIVER TRANSPLANT INFERIOR VENA CAVA STENOSIS IN A LARGE VOLUME UK CENTRE. | Fanourios Georgiades | Received |
356-OP | PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES | Domenico Pinelli | Received |
357-OP | EFFECT OF PRE-TRANSPLANT SARCOPENIA ON THE ESTIMATION OF STANDARD LIVER VOLUME IN LIVING-DONOR LIVER TRANSPLANT CANDIDATES | Riccardo Pravisani | Received |
358-OP | A PROSPECTIVE ANALYSIS OF CLINICAL FRAILTY ASSESSMENT AND TELOMERE LENGTH IN A NATIONAL COHORT OF LIVER TRANSPLANT CANDIDATES | Sinead Cremen | Received |
359-OP | FAST-TRACK LIVER TRANSPLANTATION: 100 MONTHS OF A FULL-FLEDGED ERAS PROTOCOL | Gonzalo Rodríguez-Laiz | Received |
360-OP | ARE WE READY FOR BARIATRIC SURGERY IN A LIVER TRANSPLANT PROGRAM? A META-ANALYSIS | Victor López-López | Received |
369-OP | OUTCOMES OF RABBIT ANTI-THYMOCYTE GLOBULIN VERSUS IL-2 RA INDUCTION THERAPIES IN 2DR MISMATCH RENAL TRANSPLANT RECIPIENTS | Hatem Ali | Received |
373-OP | GRAFT UTILIZATION AFTER NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH - 5-YEAR EXPERIENCE FROM FRANCE | Xavier Muller | Received |
374-OP | HYPOTHERMIC OXYGENATED MACHINE PERFUSION (HOPE) IN LIVER TRANSPLANTATION FOR EXPANDED CRITERIA DONOR GRAFT: SINGLE CENTER EXPERIENCE | Luca Perin | Received |
380-OP | OPERATIONAL TOLERANCE-RELATED GENES ALLOW NON-INVASIVE DETECTION OF SUBCLINICAL REJECTION AT ONE YEAR AFTER RENAL TRANSPLANTATION | Richard Danger | Received |
382-OP | AGE-RELATED PROTEOMIC DIFFERENCES IN DECEASED DONOR KIDNEYS ASSOCIATE WITH 12-MONTH POSTTRANSPLANTATION OUTCOME | Philip Charles | Received |
384-OP | SUBOPTIMAL RECIPIENT OUTCOMES CORRELATE TO INCREASED INFLAMMATORY MARKERS IN DECEASED AFTER BRAIN DEATH DONORS | Rebecca Vaughan | Received |
387-OP | THE EFFECT OF DONOR DIABETES-ASSOCIATED GENOTYPES ON OUTCOMES AFTER PANCREAS TRANSPLANTATION. | Charles Sneddon | Received |
388-OP | PANCREAS TRANSPLANTATION FROM DONORS DECLARED DEATH BY CIRCULATORY CRITERIA: INITIAL EXPERIENCE IN SPAIN. | Joana Ferrer | Received |
389-OP | METABOLIC OUTCOMES OF PANCREAS TRANSPLANT ALONE FROM DONATION AFTER CIRCULATORY DEATH DONORS - THE UK REGISTRY ANALYSIS | Jeevan Gopal | Received |
390-OP | HUMAN AMNIOTIC EPITHELIAL CELLS PROTECT PANCREATIC ISLETS AGAINST PRO-INFLAMMATORY CYTOKINES | Fanny Lebreton | Received |
391-OP | OUTCOMES OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS FROM DONATION AFTER CIRCULATORY DEATH DONORS IN THE UK: A NATIONAL REGISTRY ANALYSIS | Nikolaos Karydis | Received |
392-OP | DEVELOPMENT OF EX VIVO NORMOTHERMIC PERFUSION AS AN INNOVATIVE METHOD TO ASSESS PANCREASES AFTER PRESERVATION | Ann Etohan Ogbemudia | Received |
393-OP | THE EUROPEAN P-PASS AND US PDRI SCORES ARE ASSOCIATED WITH INCREASED RISK OF PANCREAS GRAFT REJECTION | Ky-Leigh Ang | Received |
394-OP | IMPROVED PANCREATIC GRAFTS SURVIVAL WITH OPERATING PROTOCOL AMENDMENTS. | Pawel Skrzypek | Received |
395-OP | POST-TRANSPLANT INFLAMMATION IS LOCALISED TO THE PANCREAS GRAFT AND ASSOCIATED WITH EARLY GRAFT THROMBOSIS | Kristina Rydenfelt | Received |
396-OP | COMPARISON OF DRB1 AND DQB1 ALLELE FREQUENCIES AND PRE-TRANSPLANT ANTI-HLA ANTIBODIES IN PATIENTS WAITING FOR PANCREAS VS. KIDNEY TRANSPLANT | Eric Kauffman | Received |
397-OP | TEN YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATIONS - SINGLE CENTRE NATIONWIDE EXPERIENCE | Kaisa Ahopelto | Received |
398-OP | PANCREAS GRAFT SALVAGE AFTER DUODENAL LEAK - FOLEY OR FOLLY? OUTCOMES FROM OVER 1000 PANCREAS TRANSPLANTS | Fungai Dengu | Received |
399-OP | FIRST POSTOPERATIVE DAY PLASMA AMYLASE CAN BE USED TO DETECT PATIENTS AT RISK OF COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Akseli Bonsdorff | Received |
400-OP | ISLETS LOADED IN HYDROGEL DERIVED FROM HUMAN AMNIOTIC MEMBRANE REVERSE DIABETES IN IMMUNODEFICIENT MICE | Kevin Bellofatto | Received |
401-OP | BLOCKADE OF THE IL-21 PATHWAY: A NEW PERSPECTIVE FOR THE TREATMENT OF T AND B CELL MEDIATED ALLOGENEIC RESPONSES AFTER TRANSPLANTATION | Carla Baan | Received |
402-OP | PROLIFERATION OF CO-STIMULATION BLOCKADE RESISTANT-T CELLS REQUIRED EARLY IFN? PATHWAY ACTIVATION | Florence Herr | Received |
403-OP | DETERMINING THE T CELLRECEPTOR REPERTOIRE IN DIRECT PEPTIDE-MHC ALLORECOGNITION BY CD8+ T CELLS | Alexandra Sharland | Received |
404-OP | INCREASED FREQUENCY OF T CELL-MEDIATED REJECTION ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN HLA-DSA NEGATIVE TRANSPLANT RECIPIENTS | David Rodriguez Fuentes. | Received |
405-OP | DO NOT BLAME THE INNOCENT: G?T CELLS ARE NOT INVOLVED IN DONOR SPECIFIC ANTIBODY GENERATION AFTER SOLID ORGAN TRANSPLANTATION | Xavier Charmetant | Received |
406-OP | IMMUNOLOGICAL BEHAVIOR OF EARLY GRAFT INFILTRATING CELLS UNTIL 3 DAYS AFTER MURINE SKIN TRANSPLANTATION | Ryo Kanazawa | Received |
407-OP | GENOME-WIDE MISMATCH AND DELETION ANALYSIS IN KIDNEY TRANSPLANTATION | Salla Markkinen | Received |
408-OP | DONOR-RECIPIENT GENETIC MISMATCH IS ASSOCIATED WITH LIVER ALLOGRAFT REJECTION | Lianne Nieuwenhuis | Received |
409-OP | SOLVENT ACCESSIBLE AMINO ACID MISMATCHES CALCULATED BY HLA-EMMA AS INDEPENDENT RISK FACTOR FOR DEATH-CENSORED GRAFT FAILURE IN RENAL TRANSPLANTATION | Suzanne Bezstarosti | Received |
410-OP | LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION | Florian Kälble | Received |
411-OP | ANTI-THYMOCYTE GLOBULIN MEDIATED B-CELL ACTIVATION | Moritz Muckenhuber | Received |
412-OP | MESENCHYMAL STROMAL CELL DERIVED MEMBRANE PARTICLES ARE INTERNALIZED BY MACROPHAGES AND ENDOTHELIAL CELLS AND EXHIBIT IMMUNOMODULATORY EFFECTS | Martin Hoogduijn | Received |
413-OP | DELINEATING THE IMMUNOGENICITY OF GRAFT COMPONENTS IN COMPOSITE TISSUE ALLOTRANSPLANTATION | Barbara Kern | Received |
414-OP | LOCAL IMMUNOSUPPRESSION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: PAVING THE WAY FOR A SAFER ALTERNATIVE | Isabel Arenas Hoyos | Received |
415-OP | MANAGEMENT OF CONGENITAL PORTOSYSTEMIC SHUNTS | Lilia Martinez de la maza | Received |
416-OP | HEPATOPORTOENTEROSTOMY VERSUS PRIMARY LIVER TRANSPLANTATION FOR BILIARY ATRESIA | Dor Yoeli | Received |
417-OP | THE ROLE OF VASCULAR ADHESION PROTEIN-1 IN THE PATHOGENESIS OF CHRONIC ALLOGRAFT HEPATITIS AFTER PAEDIATRIC LIVER TRANSPLANTATION | Steffen Hartleif | Received |
418-OP | VEIN OUTFLOW OBSTRUCTION AFTER LEFT LATERAL SEGMENTS TRANSPLANT: EXPERIENCE AT A LARGE PEDIATRIC TRANSPLANTATION CENTER. | Domenico Pinelli | Received |
419-OP | LIVER TRANSPLANTATION FOR LANGERHANS CELL HISTIOCYTOSIS : A PROTOCOL BASED APPROACH | Jagadeesh Menon | Received |
421-OP | KIDNEY TRANSPLANTATION IN THE TRANSGENDER PATIENT- A CHALLENGE FOR CARE | Irena Milaniak | Received |
422-OP | FIRST PERSON CONSENT: CHALLENGES TO APPROACHING FOR DONATION. | Bethany Hall | Received |
424-OP | COLLABORATIVE WORKING- KEY TO MAINTAINING NORMAL ORGAN DONATION AND TRANSPLANT SERVICE DURING COVID PANDEMIC IN NORTHERN IRELAND | Mary Hayes | Received |
431-OP | SYSTEMATIC SCREENING FOR SARS-COV-2 S1/S2 ANTIBODIES HELPS TO BETTER ASSESS THE REAL INCIDENCE OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS | Louis Firket | Received |
432-OP | COMPARISON OF THE IMMUNE RESPONSES OF RENAL TRANSPLANT RECIPIENTS AFTER COVID-19 VERSUS SARS-COV2 VACCINATION | Xavier Charmetant | Received |
434-OP | INCREASE ORGANS PROCURED AND TRANSPLANTED VIA A COMPREHENSIVE, INTEROPERABLE, AND SECURE DIGITAL DONOR AND TRANSPLANT MANAGEMENT PLATFORM | John Piano | Received |
435-OP | IMPACT ON DONOR DETECTION AFTER THE IMPLEMENTATION OF QUALITY INDICATORS AND TPM TRAINING PROGRAM IN THE KINGDOM OF SAUDI ARABIA | Estephan Arredondo | Received |
436-OP | THE DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION FROM 1998 TO 2019: RESULTS | Carlo De Cillia | Received |
437-OP | ORGAN DONATION AND TRANSPLANT IN THE ENGLISH-SPEAKING CARIBBEAN REGION: 10 YEARS OF INTERNATIONAL COOPERATION | Maria Gomez | Received |
438-OP | QUALITY MANAGEMENT SYSTEM APPLIED TO ORGAN DONATION: UNITED ARAB EMIRATES EXPERIENCE | Maria Gomez | Received |
439-OP | SOLUBLE UROKINASE RECEPTOR AND MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS | Christian Morath | Received |
440-OP | COMPARATIVE TRANSCRIPTOME ANALYSIS REVEALS A POTENTIAL ROLE OF C1QB IN CHRONIC ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFS. | Mattia Rossi | Received |
441-OP | VALIDATION OF FLAVIN MONONUCLEOTIDE TO MONITOR QUALITY OF DONOR KIDNEYS DURING HYPOTHERMIC (OXYGENATED) MACHINE PERFUSION IN KIDNEY TRANSPLANTATION | Fenna Van De Leemkolk | Received |
442-OP | MONITORING OF MOLECULAR PROFILING OF REGULATORY T CELL BIOMARKERS BY USING NON-INVASIVE STRATEGIES TO PREDICT OUTCOME IN RENAL TRANSPLANTATION. | Angelica Canossi | Received |
443-OP | URINARY EXTRACELLULAR VESICLES AND VESICULAR CELL-FREE DNA AS POTENTIAL BIOMARKERS FOR KIDNEY ALLOGRAFT INJURY | Ivana Sedej | Received |
444-OP | NUCLEAR FACTOR OF ACTIVATED T CELLS AS POTENTIAL PHARMACODYNAMIC BIOMARKER FOR THE RISK OF ACUTE AND SUBCLINICAL REJECTION IN LIVER RECIPIENTS | Olga Millan | Received |
445-OP | CONNECTION OF BANK1, TOLERANCE, REGULATORY B CELLS, AND APOPTOSIS: PERSPECTIVES OF A REDUCTIONIST INVESTIGATION. | Ludmilla Le Berre | Received |
446-OP | IMPACT OF STEATOSIS AND COLD ISCHEMIA TIME ON MITOCHONDRIAL RESPIRATION IN HUMAN LIVER ALLOGRAFTS | Andras T. Meszaros | Received |
447-OP | APPLICATION OF THIN-FILM SOLID-PHASE MICROEXTRACTION TO BILE ANALYSIS - BILE FINGERPRINT AS A PROGNOSTIC MARKER DURING LIVER TRANSPLANTATION | Kamil Luczykowski | Received |
448-OP | VIABILITY ASSESSMENT USING THE "SIX GENE SIGNATURE" DURING LIVER PERFUSION | Rodrigo Figuerido | Received |
449-OP | ADVANTAGES OF PLASMATIC CXCL10 AS A PROGNOSTIC & DIAGNOSTIC BIOMARKER FOR THE RISK OF REJECTION AND SUBCLINICAL REJECTION IN KIDNEY TRANSPLANTATION. | Olga Millan | Received |
450-OP | MONITORING KIDNEY GRAFT INJURY BY MEASURING DONOR-DERIVED CELL FREE DNA (DD-CFDNA) | Emilio Rodrigo | Received |
451-OP | HUMAN CD81 EXTRACELLULAR VESICLES ARE RELEASED DURING NORMOTHERMIC MACHINE PERFUSION | Wouter Woud | Received |
452-OP | TRANSFORMING GROWTH FACTOR-?1 EXPRESSION IN RENAL TRANSPLANT URETER TISSUE AND POST-TRANSPLANT URETERAL STRICTURE | Emmy Hartog | Received |
454-OP | TREAT-TO-TARGET TRIAL OF CONTINUOUS SUBCUTANEOUS INSULIN-PUMP THERAPY IN NEW-ONSET DIABETES AFTER TRANSPLANTATION (SAPT-NODAT) | Amelie Kurnikowski | Received |
455-OP | SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITORS IN RENAL TRANSPLANT DIABETIC PATIENTS. SINGLE CENTER PILOT STUDY. | Claudia Muñoz Martínez | Received |
461-OP | PROPHYLACTIC DESENSITIZATION IN LUNG TRANSPLANT CANDIDATES WITH PRE-FORMED DONOR-SPECIFIC ANTIBODIES: 3-YEAR POST-TRANSPLANTATION OUTCOME. | Olivier Brugière | Received |
462-OP | LUNG TRANSPLANT RECIPIENTS DEVELOPING EARLY DSA WITHIN THE FIRST MONTH EXHIBIT A HIGHER FREQUENCY OF NAÏVE AND A LOWER FREQUENCY OF MEMORY B CELLS | Stella Christoph | Received |
463-OP | ALTERATION OF T LYMPHOCYTE SUBPOPULATIONS IN LUNG TRANSPLANTED PATIENT RECEIVING PROPHYLACTIC EXTRACORPOREAL PHOTOPHERESIS | Ara Cho | Received |
464-OP | PARTICLE FLOW RATE FROM THE AIRWAYS AS A MARKER FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) | Embla Bodén | Received |
466-OP | KAPOSI´S SARCOMA (KS) IN PEDIATRIC LIVER TRANSPLANTATION (LT) – 3 CLINICAL CASES | Catarina Cordeiro | Received |
469-OP | LONG TERM SURVIVAL AFTER CHORIOCARCINOMA TRANSMITTED BY LIVER GRAFT: A SUCCESSFUL REPORT IN PAEDIATRIC TRANSPLANTATION | Inês Pessanha | Received |
477-OP | CIRCULATING AND INTRAGRAFT DONOR(HLA)-SPECIFIC B CELLS DRIVE ANTIBODY-MEDIATED REJECTION IN HEART AND KIDNEY TRANSPLANT PATIENTS | Alba Torija | Received |
478-OP | ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFT IS ASSOCIATED WITH AN INCREASE IN DIFFERENTIATED CD28-CD8+ T CELLS IN THE PERIPHERAL BLOOD | Hoa Mai | Received |
479-OP | CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES PROTECT AGAINST CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Patricia Suàrez Fernández | Received |
480-OP | ANTIVIRAL TREATMENT PATTERNS FOR CYTOMEGALOVIRUS PREVENTION AMONG ADULT KIDNEY TRANSPLANT RECIPIENTS: A USRDS-MEDICARE LINKED DATABASE STUDY | Carlos Santos | Received |
481-OP | DONOR CYTOMEGALOVIRUS SEROPOSITIVITY CLUSTERS WITH RISK FACTORS FOR DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTATION, BUT DOES NOT DIRECTLY CONTRIBUTE | Richard Dumbill | Received |
482-OP | PREVENTION OF CYTOMEGALOVIRUS INFECTION BY EVEROLIMUS IN SEROPOSITIVE KIDNEY TRANSPLANT RECIPIENTS | Lionel Couzi | Received |
483-OP | VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY FOR PREVENTION OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS: A RANDOMIZED CONTROLLED TRIAL | Tomas Reischig | Received |
484-OP | INFECTION PATTERN IN EVEROLIMUS VERSUS MYCOPHENOLATE-BASED REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH RESULTS FROM THE TRANSFORM STUDY | Franco Citterio | Received |
485-OP | OUTCOME OF EBV NEGATIVE RECIPIENTS OF EBV POSITIVE DONOR ORGAN TRANSPLANT IN A SINGLE CENTRE | Caroline Dudreuilh | Received |
486-OP | TACROLIMUS METABOLISM RATE AND BK INFECTION IN RENAL TRANSPLANT PATIENTS | Dalvir Kular | Received |
487-OP | RELATIONSHIP BETWEEN CARBAPENEM-RESISTANT ENTEROBACTERALES CARRIAGE AND GUT MICROBIOME AFTER LIVER TRANSPLANTATION: A PROSPECTIVE COHORT STUDY | Matteo Rinaldi | Received |
488-OP | ASSOCIATION BETWEEN ACUTE GRAFT PYELONEPHRITIS AND KIDNEY GRAFT LOSS: A SINGLE-CENTER OBSERVATIONAL STUDY | Mehdi Maanaoui | Received |
489-OP | BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS: RESULT FROM A DANISH COHORT WITH NATIONWIDE FOLLOW-UP | Dina Leth Møller | Received |
490-OP | ENTEROCOCCAL INFECTIONS IN THE FIRST YEAR AFTER LIVER TRANSPLANTATION | Daniel Bräuner Rasmussen | Received |
491-OP | SUPERFICIAL SURGICAL SITE INFECTION AT HAND-PORT SITE AFTER HAND ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY FOR LIVING DONOR KIDNEY TRANSPLANTATION | Takahisa Hiramitsu | Received |
492-OP | CONTROLLED DONATION AFTER CIRCULATORY DEATH: IS THERE A RISK FACTOR OF CULTURE-POSITIVE PRESERVATION FLUID ON SOLID ORGANS FOR TRANSPLANTATION? | María Figueras | Received |
493-OP | THE "CRITICAL PATHWAY" FOR TISSUE DONATION: NEW DEFINITIONS FOR A COMMON AND SYSTEMATIC EUROPEAN APPROACH TO DECEASED DONOR TISSUE DONATION. | Alberto Sandiumenge | Received |
494-OP | HOW DO SPANISH TRANSPLANT COORDINATORS APPROACH RELATIVES FOR CONSENT TO INTENSIVE CARE FOR ORGAN DONATION? RESULTS OF AN EMPIRICAL STUDY | Rubén García-Sánchez | Received |
495-OP | ITALIAN SURVEY ON THE OPINIONS OF PROFESSIONALS FROM TRANSPLANT AND INTENSIVE CARE AREAS ABOUT COVID-19 AND SOLID ORGAN TRANSPLANTATION ACTIVITY | Federica Galiandro | Received |
496-OP | APPLICATION OF THEORY OF PLANNED BEHAVIOR ON ORGAN DONATION BEHAVIOR: A SYSTEMATIC REVIEW | Marzieh Latifi | Received |
497-OP | EUDONORGAN: A SUCCESSFUL TRAINING PROGRAM TO IMPROVE ORGAN DONATION KNOWLEDGE IN THE EUROPEAN UNION AND NEIGHBOURING COUNTRIES. | Patricia Peralta Lasso | Received |
498-OP | CONDITIONS THAT INFLUENCE FAMILY CONSENT FOR INTENSIVE CARE FOR ORGAN DONATION: THE PERSPECTIVE OF SPANISH TRANSPLANT COORDINATORS | Jorge S. López | Received |
499-OP | ENLIGHTENING YOUNG MINDS: A SMALL STEP IN THE CURRICULUM, A GIANT LEAP IN ORGAN DONATION - A SURVEY OF 996 RESPONDENTS ON ORGAN DONATION | Abdul Rahman Hakeem | Received |
500-OP | SEIZING THE POTENTIAL RISK OF TRANSMISSION OF OLIGODENDROGLIOMA TO RECIPIENTS | Serena Ammendola | Received |
501-OP | OUT-OF-HOSPITAL DONORS WITH IRREVERSIBLE CARDIAC ARREST IN RUSSIA: ONE OF THE PROMISING RECOURSE ACCORDING THE FIRST ST PETERSBURG EXPERIENCE | Andrey Skvortsov | Received |
502-OP | WHAT HAPPENS TO UNSPECIFIED KIDNEY DONOR CANDIDATES WHO CANNOT PROCEED TO DONATE: AN INDUCTIVE THEMATIC ANALYSIS FROM THE BOUND STUDY | Mira Zuchowski | Received |
503-OP | DECEASED DONOR TRANSPLANTATION DURING COVID TIMES - SUCCESS STORY FROM STATE IN INDIA. | Maria Gomez | Received |
504-OP | NEW TECHNOLOGIES APPLIED TO MASTER EDUCATION IN THE TIME OF COVID-19 | Chloe Balleste | Received |
505-OP | IMPACT OF THE SARS-COV-2 PANDEMIC ON TISSUE DONATION IN CATALONIA | Belen Garcés Jimeno | Received |
506-OP | EFFECTS OF THE SARS-COV2 PANDEMIC ON ORGAN OFFERS IN EUROPE | Federica Domini | Received |
508-OP | A NATIONAL SURVEY ON ENHANCED RECOVERY FOR RENAL TRANSPLANT RECIPIENTS: CURRENT PRACTICES AND TRENDS IN THE UNITED KINGDOM | Carrie Scuffell | Received |
509-OP | ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR RENAL TRANSPLANT RECIPIENTS: THE EARLY NEWCASTLE EXPERIENCE | Carrie Scuffell | Received |
510-OP | POSITIVE IMPACT OF ERAS PROGRAMME ON LIVING AND DECEASED DONOR RENAL TRANSPLANT RECIPIENTS DURING COVID PANDEMIC | Rachel Thomas | Received |
511-OP | FACTORS ASSOCIATED WITH PROLONGED LENGTH OF STAY FOLLOWING RENAL TRANSPLANTATION: A NURSE LED AUDIT | Leigh Whinham | Received |
514-OP | TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL. | Annelies De Weerd | Received |
515-OP | COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VS LCPT. | Gionata Spagnoletti | Received |
516-OP | OUTCOMES OF IL2-RA INDUCTION THERAPY IN STANDARD-RISK RENAL TRANSPLANT RECIPIENTS MAINTAINED ON TACROLIMUS - A META-ANALYSIS | Hatem Ali | Received |
519-OP | MESENCHYMAL STROMAL CELLS COMBINED WITH EVEROLIMUS PROMOTE T REG EXPANSION BUT DO NOT SYNERGIZE IN A RAT LIVER TRANSPLANT REJECTION MODEL | Morgan Vandermeulen | Received |
520-OP | EFFICIENT EXPANSION OF HUMAN GRANZYME B–EXPRESSING B CELLS WITH POTENT REGULATORY PROPERTIES | Hoa Mai | Received |
521-OP | GAMMA-DELTA T CELL THERAPY FOR THE TREATMENT OF POST-TRANSPLANT CMV INFECTION: PROOF OF CONCEPT | Gabriel Marseres | Received |
524-OP | CHARACTERIZATION OF MESENCHYMAL STEM CELL INDUCED REGULATORY B CELLS (MSC-INDUCED BREG) | Sergio G. Garcia | Received |
700-OP | MULTI-OMICS DATA INTEGRATION IN KIDNEY TRANSPLANTATION: THE HIDDEN PATHWAYS OF ANTIBODY-MEDIATED REJECTION | Claire Tinel | Received |
701-OP | DEEP PHENOTYPING OF HUMAN KIDNEY TRANSPLANT REJECTION USING SINGLE-CELL TRANSCRIPTOMICS | Baptiste Lamarthée | Received |
702-OP | REAL WORLD USE AND CLINICAL IMPACT OF EXTRACORPOREAL PHOTOPHERESIS IN HEART TRANSPLANT PATIENTS – RESULTS FROM A EUROPEAN MULTICENTER STUDY | Markus J. Barten | Received |
703-OP | EPLETS INCOMPATIBILITY AS A DETERMINANT IN EXPOSURE TO TACROLIMUS | Christian Córdoba Herrera | Received |
713-OP | DONATION AFTER CIRCULATORY DEATH (DCD) DONORS IN THE EMILIA-ROMAGNA REGION (ERR): OUR FIRST FORTY CASES | Carlo De Cillia | Received |
716-OP | POST-VACCINE IMMUNITY TO COVID-19 VACCINE IN END-STAGE RENAL DISEASE PATIENTS AND KIDNEY TRANSPLANT RECIPIENT | Magdalena Piotrowska | Received |
717-OP | ACUTE KIDNEY INJURY AFTER HEART TRANSPLANTATION: ROLE OF INTRAOPERATIVE MANAGEMENT | Veronica Moriconi | Received |
718-OP | METABOLIC OUTCOMES AFTER PANCREAS TRANSPLANTATION FROM DONORS AFTER CIRCULATORY DEATH - THE UK REGISTRY ANALYSIS | Jeevan Gopal | Received |
719-OP | PORTABLE GAMMA-CAMERA AS A USEFUL TOOL FOR BRAIN DEATH DIAGNOSIS | José Moya Sánchez | Received |
720-OP | SPECIFIC URINARY METABOLOMIC PROFILE IN SPONTANEOUS TOLERANT KIDNEY TRANSPLANTED RECIPIENTS | Luc Colas | Received |
721-OP | DESIGN OF STEADFAST STUDY EVALUATING TX200-TR101, A CHIMERIC ANTIGEN RECEPTOR T?REGULATORY CELL THERAPY FOR LIVING DONOR RENAL TRANSPLANT RECIPIENTS | Emily Culme-Seymour | Received |
722-OP | EARLY SAFETY OF SARS-COV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS | Michael Ou | Received |
723-OP | IDOTCOVID- INTERNATIONAL DATABASE ON ORGAN DONATION AND TRANSPLANTATION - COVID 19 | Pedro Ventura-Aguiar | Received |
724-OP | LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-COV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Brian Boyarsky | Received |
725-OP | SARS-COV 2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS | Renato Pascale | Received |
726-OP | PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE, UNCERTAINTY AND COPING STRATEGIES IN ORGAN TRANSPLANT RECIPIENTS DURING THE COVID PANDEMIC | Angus Hann | Received |
727-OP | MOTIVATION, EXPERIENCES, AND MENTAL HEALTH OUTCOMES OF UNSPECIFIED KIDNEY DONORS IN THE NETHERLANDS: A QUALITATIVE STUDY | Mathilde Pronk | Received |
728-OP | FIVE YEAR HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS PLUS REDUCED TACROLIMUS VS STANDARD TACROLIMUS AFTER LIVING-DONOR LIVER TRANSPLANTATION | Gonzalo Sapisochin | Received |
729-OP | PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Reshma Rana Magar | Received |
Aug 29 - Sept 1, 2021 Milano
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|